[go: up one dir, main page]

WO2002062984A1 - The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof - Google Patents

The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof Download PDF

Info

Publication number
WO2002062984A1
WO2002062984A1 PCT/CN2001/000117 CN0100117W WO02062984A1 WO 2002062984 A1 WO2002062984 A1 WO 2002062984A1 CN 0100117 W CN0100117 W CN 0100117W WO 02062984 A1 WO02062984 A1 WO 02062984A1
Authority
WO
WIPO (PCT)
Prior art keywords
cell
yeast
biological preparations
specific
immonological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2001/000117
Other languages
French (fr)
Chinese (zh)
Inventor
Kamfu Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SIX FOREST BIO-SCIENCE INSTITUTE Ltd
Original Assignee
SIX FOREST BIO-SCIENCE INSTITUTE Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SIX FOREST BIO-SCIENCE INSTITUTE Ltd filed Critical SIX FOREST BIO-SCIENCE INSTITUTE Ltd
Priority to PCT/CN2001/000117 priority Critical patent/WO2002062984A1/en
Publication of WO2002062984A1 publication Critical patent/WO2002062984A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention involves a method of simulating bioelectricity to activate the recessive gene of normal yeast to convert it a specific yeast. The specific proteins (enzymes) expressed by the specific yeast have the ability to activate, modulate and correct the immune gene in the B cell, T cell, K cell and NK cell which have deficient immonological function, respectively. Further more, the specific yeast is made into biological preparations for regulating the immune gene to rebuild immonological function of the body, such that the individuals with various diseases can recuperate their health. The biological preparations of the invention may be used in preventing and treating various diseases such as multiple type of tumors, uraemia, hepatitis, senile dementia, various gastrointestinal disease, diabetes, neural obstruction etc. The effect of the biological preparations is perfect, while no toxicity and side-effect is observed.
PCT/CN2001/000117 2001-02-08 2001-02-08 The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof Ceased WO2002062984A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CN2001/000117 WO2002062984A1 (en) 2001-02-08 2001-02-08 The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2001/000117 WO2002062984A1 (en) 2001-02-08 2001-02-08 The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof

Publications (1)

Publication Number Publication Date
WO2002062984A1 true WO2002062984A1 (en) 2002-08-15

Family

ID=4574771

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000117 Ceased WO2002062984A1 (en) 2001-02-08 2001-02-08 The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof

Country Status (1)

Country Link
WO (1) WO2002062984A1 (en)

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1375652A3 (en) * 2002-06-28 2004-01-07 Ultra Biotech Limited Oral compositions for HIV-Infected Subjects
EP1375651A3 (en) * 2002-06-28 2004-01-07 Ultra Biotech Limited Oral compositions for white blood cell activation and proliferation
US6913913B2 (en) 2003-11-18 2005-07-05 Ultra Biotech Limited Methods and compositions for treating renal failure
US6913914B2 (en) 2003-11-18 2005-07-05 Ultra Biotech Limited Methods and compositions for treating hepatitis B
US6964864B2 (en) 2003-11-18 2005-11-15 Ultra Biotech Limited Methods and compositions for treating gastritis
US6977168B2 (en) 2003-11-18 2005-12-20 Ultra Biotech Limited Methods and compositions for treating nephrotic syndrome
US6979562B2 (en) 2003-11-18 2005-12-27 Ultra Biotech Limited Methods and compositions for treating gastroparesis
US6984507B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of lung cancer
US6984508B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of cervical cancer
US6987012B2 (en) 2003-06-11 2006-01-17 Ultra Biotech Limited Biological compositions and methods for treatment of colorectal cancer
US6989253B2 (en) 2003-06-11 2006-01-24 Ultra Biotech Limited Biological compositions and methods for treatment of testicular cancer
US7078202B2 (en) 2003-11-18 2006-07-18 Ultra Biotech Limited Methods and compositions for treating vascular dementia
US7201906B2 (en) 2003-06-11 2007-04-10 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204988B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204986B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204987B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Biological compositions and methods for treatment of prostate cancer
US7208158B2 (en) 2003-06-11 2007-04-24 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7214377B2 (en) 2003-06-11 2007-05-08 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7220416B2 (en) 2003-06-11 2007-05-22 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223404B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223402B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223405B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepareompositions comprising yeast treated with electromagnetic energy
US7223400B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223403B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223401B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7226600B2 (en) 2003-06-11 2007-06-05 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7259001B2 (en) 2003-11-18 2007-08-21 Ultra Biotech Limited Methods and compositions for treating male sexual dysfunction
US7297522B2 (en) 2003-11-18 2007-11-20 Ultra Biotech Limited Methods and compositions for treating epilepsy
WO2011023769A1 (en) * 2009-08-26 2011-03-03 Mb Milmed Ab Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU902462A1 (en) * 1980-03-26 1982-08-15 Отдел Биологии Дагестанского Филиала Ан Ссср Method for cultivating yeast
SU1514777A1 (en) * 1987-06-30 1989-10-15 Inst Molekulyarnoj Biolog An S Method of producing biomass of saccharomyces cerevisial yeast
CN1185484A (en) * 1996-12-11 1998-06-24 阿尔瓦罗·V·皮卡卢加 Methods of modulating cell behavior

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU902462A1 (en) * 1980-03-26 1982-08-15 Отдел Биологии Дагестанского Филиала Ан Ссср Method for cultivating yeast
SU1514777A1 (en) * 1987-06-30 1989-10-15 Inst Molekulyarnoj Biolog An S Method of producing biomass of saccharomyces cerevisial yeast
CN1185484A (en) * 1996-12-11 1998-06-24 阿尔瓦罗·V·皮卡卢加 Methods of modulating cell behavior

Cited By (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1375652A3 (en) * 2002-06-28 2004-01-07 Ultra Biotech Limited Oral compositions for HIV-Infected Subjects
EP1375651A3 (en) * 2002-06-28 2004-01-07 Ultra Biotech Limited Oral compositions for white blood cell activation and proliferation
US7204987B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Biological compositions and methods for treatment of prostate cancer
US7172888B2 (en) 2003-06-11 2007-02-06 Ultra Biotech Limited Biological compositions and methods for treatment of lung cancer
US7226600B2 (en) 2003-06-11 2007-06-05 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223401B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223403B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US6984507B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of lung cancer
US6984508B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of cervical cancer
US6987012B2 (en) 2003-06-11 2006-01-17 Ultra Biotech Limited Biological compositions and methods for treatment of colorectal cancer
US6989253B2 (en) 2003-06-11 2006-01-24 Ultra Biotech Limited Biological compositions and methods for treatment of testicular cancer
US7223400B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7163813B2 (en) 2003-06-11 2007-01-16 Ultra Biotech Limited Biological compositions and methods for treatment of colorectal cancer
US7223404B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7172889B2 (en) 2003-06-11 2007-02-06 Ultra Biotech Limited Biological compositions and methods for treatment of cervical cancer
US7201906B2 (en) 2003-06-11 2007-04-10 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204988B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204986B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223405B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepareompositions comprising yeast treated with electromagnetic energy
US7223402B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7208158B2 (en) 2003-06-11 2007-04-24 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7214377B2 (en) 2003-06-11 2007-05-08 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7220416B2 (en) 2003-06-11 2007-05-22 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7078202B2 (en) 2003-11-18 2006-07-18 Ultra Biotech Limited Methods and compositions for treating vascular dementia
US7208159B2 (en) 2003-11-18 2007-04-24 Ultra Biotech Limited Methods and compositions for treating gastroparesis
US6913914B2 (en) 2003-11-18 2005-07-05 Ultra Biotech Limited Methods and compositions for treating hepatitis B
US6913913B2 (en) 2003-11-18 2005-07-05 Ultra Biotech Limited Methods and compositions for treating renal failure
US6979562B2 (en) 2003-11-18 2005-12-27 Ultra Biotech Limited Methods and compositions for treating gastroparesis
US6977168B2 (en) 2003-11-18 2005-12-20 Ultra Biotech Limited Methods and compositions for treating nephrotic syndrome
US6964864B2 (en) 2003-11-18 2005-11-15 Ultra Biotech Limited Methods and compositions for treating gastritis
US7259001B2 (en) 2003-11-18 2007-08-21 Ultra Biotech Limited Methods and compositions for treating male sexual dysfunction
US7297522B2 (en) 2003-11-18 2007-11-20 Ultra Biotech Limited Methods and compositions for treating epilepsy
WO2011023769A1 (en) * 2009-08-26 2011-03-03 Mb Milmed Ab Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast
CN102481368A (en) * 2009-08-26 2012-05-30 密美德有限公司 Compositions, methods and uses of yeast comprising electromagnetic radiation for the treatment of neurodegenerative diseases or conditions
JP2013503138A (en) * 2009-08-26 2013-01-31 エムビー ミルメド エービー Compositions, methods and uses for the treatment of neurodegenerative diseases or disorders comprising electromagnetic radiation yeast
CN102481368B (en) * 2009-08-26 2014-01-29 密美德有限公司 Compositions, methods and uses of yeast comprising electromagnetic radiation for the treatment of neurodegenerative diseases or conditions
US9320768B2 (en) 2009-08-26 2016-04-26 Milmed Ab Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast

Similar Documents

Publication Publication Date Title
WO2002062984A1 (en) The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof
WO2002062981A1 (en) A yeast human immunoregulator and the method for preparing it
Balakrishnan et al. The role of Amaranth, quinoa, and millets for the development of healthy, sustainable food products—a concise review
WO2002062983A1 (en) A yeast with t cell immunoregulatory activity as well as the preparing method and the uses thereof
WO2002062985A1 (en) A yeast with nk cell immunoregulatory activity as well as the preparing method and the uses thereof
WO2002062982A1 (en) A yeast having b cell immune regulation activity and its preparation method and application thereof
Copenhaver et al. IL-1R signaling enables bystander cells to overcome bacterial blockade of host protein synthesis
Li et al. Investigation of Chlorella pyrenoidosa protein as a source of novel angiotensin I-converting enzyme (ACE) and dipeptidyl peptidase-IV (DPP-IV) inhibitory peptides
Osiewacz et al. Mitochondrial quality control: impact on aging and life span-a mini-review
EP4269561A3 (en) Improved modalities for the treatment of degenerative diseases of the retina
WO2007117438A3 (en) Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith
Sagu et al. Comprehensive characterization and relative quantification of α-amylase/trypsin inhibitors from wheat cultivars by targeted HPLC-MS/MS
Hu et al. Purification and identification of novel xanthine oxidase inhibitory peptides derived from round scad (Decapterus maruadsi) protein hydrolysates
WO2007150067A3 (en) Nutritional and exercise plan based on a person's individual genetic apo e genotype
WO2005058945A3 (en) Gene variants coding for proteins from the metabolic pathway of fine chemicals
Chen et al. Development and optimization of djulis sourdough bread fermented by lactic acid bacteria for antioxidant capacity
Laurent-Babot et al. Should research on the nutritional potential and health benefits of fermented cereals focus more on the general health status of populations in developing countries?
Kęska et al. Stability of antiradical activity of protein extracts and hydrolysates from dry-cured pork loins with probiotic strains of LAB
Ulvestad Psychoneuroimmunology: the experiential dimension
Cappello et al. Identification and selection of prospective probiotics for enhancing gastrointestinal digestion: Application in pharmaceutical preparations and dietary supplements
Kawa et al. Locomotor activity, object exploration and space preference in children with autism and Down syndrome
Starzyńska-Janiszewska et al. Phenolic profile, antioxidant activity and amino acid composition of moringa leaves fermented with edible fungal strains
Okabe et al. Autism Spectrum Disorder-and/or Intellectual Disability-Associated Semaphorin-5A Exploits the Mechanism by Which Dock5 Signalosome Molecules Control Cell Shape
WO2006122971A3 (en) Treatment of disease using an improved regulated expression system
Garrido-Ortiz et al. Production of Protein Hydrolysates with Antioxidant and Antihypertensive Activity from Edible Larvae of Aegiale hesperiaris and Comadia redtenbacheri

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP